Stock Track | Clover Health Plummets 5.35% Intraday on Mixed Earnings and 2026 Guidance Concerns

Stock Track
02/27

Clover Health Corp (CLOV) saw its stock price plummet by 5.35% during intraday trading on Friday.

The decline follows the company's release of mixed quarterly financial results and forward-looking guidance. Clover Health reported a quarterly adjusted loss of 10 cents per share for the period ended September 30, 2025, with revenue growing 47.4% year-over-year to $487.71 million. However, the company posted a substantial quarterly loss of $49.32 million, representing a deterioration from the same quarter last year.

Investors reacted negatively to the company's full-year 2026 revenue guidance of $2.81 billion to $2.92 billion, indicating concerns about continued losses despite revenue growth and uncertainty over the path to profitability.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10